Financial statements Horten Bio
Balance sheet data of HORTEN BIO
|
Year
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 80 846,30 | 79 557,80 | 47 847,97 | 17 609,74 |
| A. Fixed assets | 37 627,00 | 42 627,00 | 0,00 | 0,00 |
| B. Current assets | 43 219,30 | 36 930,80 | 47 847,97 | 17 609,74 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 80 846,30 | 79 557,80 | 47 847,97 | 17 609,74 |
| A. Equity | 5 746,30 | 2 920,30 | -18 789,53 | -46 614,74 |
| B. Liabilities and provisions for liabilities | 75 100,00 | 76 637,50 | 66 637,50 | 64 224,48 |
| I. Long-term liabilities | 75 100,00 | 75 100,00 | - | - |
| II. Short-term liabilities | 0,00 | 1 537,50 | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.